CerraCap Ventures Invests in Nephronomics for AI Kidney Disease Research

Apr 21, 2026
CerraCap Ventures has invested in Nephronomics, an AI bio precision medicine company developing data driven approaches to kidney disease research and drug discovery. The partnership aims to advance precision therapies using one of the largest renal datasets in the world.

CerraCap Ventures has invested in Nephronomics, an AI bio precision medicine company focused on kidney disease, announced in a press release. The investment supports Nephronomics' goal of advancing precision therapies for cardio kidney metabolic disease through large scale data analysis.

Nephronomics is building a comprehensive clinical and genomic dataset covering more than 42,000 patients from dialysis clinics across the United States. Its platform applies machine learning to identify disease subtypes, reveal causal mechanisms, and discover new therapeutic targets for chronic kidney disease.

According to the announcement, Nephronomics holds exclusive access to one of the largest renal datasets globally, which includes whole genome and longitudinal clinical data. The company plans to use this resource to develop internal drug programs and collaborate with pharmaceutical partners.

CerraCap Ventures, based in Southern California, focuses on early stage enterprise technology investments. The firm said the partnership with Nephronomics aligns with its strategy of supporting companies that apply AI to create new models for healthcare innovation.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Enterprise AI Brief, AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI AI Funding News AI Brief AI Brief (X)
Free newsletter

AI Funding Brief

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.